Dengue and dengue hemorrhagic fever.
- 1 July 1998
- journal article
- review article
- Vol. 11 (3), 480-96
Abstract
Dengue fever, a very old disease, has reemerged in the past 20 years with an expanded geographic distribution of both the viruses and the mosquito vectors, increased epidemic activity, the development of hyperendemicity (the cocirculation of multiple serotypes), and the emergence of dengue hemorrhagic fever in new geographic regions. In 1998 this mosquito-borne disease is the most important tropical infectious disease after malaria, with an estimated 100 million cases of dengue fever, 500,000 cases of dengue hemorrhagic fever, and 25,000 deaths annually. The reasons for this resurgence and emergence of dengue hemorrhagic fever in the waning years of the 20th century are complex and not fully understood, but demographic, societal, and public health infrastructure changes in the past 30 years have contributed greatly. This paper reviews the changing epidemiology of dengue and dengue hemorrhagic fever by geographic region, the natural history and transmission cycles, clinical diagnosis of both dengue fever and dengue hemorrhagic fever, serologic and virologic laboratory diagnoses, pathogenesis, surveillance, prevention, and control. A major challenge for public health officials in all tropical areas of the world is to develop and implement sustainable prevention and control programs that will reverse the trend of emergent dengue hemorrhagic fever.This publication has 98 references indexed in Scilit:
- Multicentre evaluation of dengue IgM dot enzyme immunoassayClinical and Diagnostic Virology, 1996
- Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)—A novel approach to the protection of humansVirus Genes, 1994
- Development of Dengue and Japanese Encephalitis VaccinesThe Journal of Infectious Diseases, 1990
- Molecular Characterization of a Neutralizing Domain of the Japanese Encephalitis Virus Structural GlycoproteinJournal of General Virology, 1989
- Dengue feverClinics in Dermatology, 1989
- Current Approaches to the Development of Dengue Vaccines and Related Aspects of the Molecular Biology of FlavivirusesThe Journal of Infectious Diseases, 1988
- Dengue Virus Type 2 Vaccine: Reactogenicity and Immunogenicity in SoldiersThe Journal of Infectious Diseases, 1984
- DETECTION OF DENGUE VIRUS BY IMMUNOFLUORESCENCE AFTER INTRACEREBRAL INOCULATION OF MOSQUITOESThe Lancet, 1982
- Antibody-enhanced dengue virus infection in primate leukocytesNature, 1977
- Studies on the Pathogenesis of Dengue Infection in Monkeys. I. Clinical Laboratory Responses to Primary InfectionThe Journal of Infectious Diseases, 1973